Analysis of Liver Function on Leprosy Patient with Multidrug Therapy in Haji Adam Malik General Hospital Medan from January until December 2017
Leprosy is a chronic progressive granulomatous disease that caused by Mycobacterium leprae, an intracellular obligate bacteria. Leprosy can be treated using multidrug therapy (MDT) that can be associated with hepatotoxicity as their side effects. We included 14 patients that were all diagnosed with multibacillary leprosy, but with four drops out persons. Liver function evaluations before MDT were in the normal range. After 1st, 2nd, and 3rd months of MDT, liver function test in research subjects also in the normal range even though there is variation in this value. There is a risk of hepatotoxicity of MDT; therefore, liver function test should be done periodically for early detection of any liver dysfunction.
Plum Analytics Artifact Widget Block
Swathi M. A study of liver function test in leprosy. Indian J Lepr. 2014;86(4):155-7. PMid:26411248
Infodatin. Pusat Data dan Informasi Kementerian Kesehatan RI; 2015. Available from: http://www.depkes.go.id. [Last accessed on 2015 Nov 23].
Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia. Data dan Informasi Tahun 2014; 2015. Available from: http://www.depkes.go.id. [Last accessed on 2015 Nov 23].
Noordin SK. Leprosy control through multi drug therapy (MDT). Bull World Health Organ. 1999;69:263-9. PMid:1893503
World Health Organization. Leprosy Today. Geneva: World Health Organization; 2014. Available from: http: www.who.int/ lep/en. [Last accessed on 2014 Dec 01].
Baymakova M. Fever of unknown origin in adults. Gen Med. 2015;17:61-8.
Krishnan SP, Kamalanathan A, John J, Gopalakrishnan S. A reminiscent review on leprosy. Med Microbiol. 2015;26:8-13.
Singh H, Nel B, Dey V, Tiwari P, Dulhani N. Adverse effect of multi drug therapy in leprosy, a two yearsâ€™ experience (2006- 2008) in tertiary health care in the tribal region of Chhattisgarh state (Bastar, Jagdalpur). Lepr Rev. 2011;82(1):17-24. https:// doi.org/10.4103/1755-6783.77188 PMid:21644468
Kar HK, Gupta R. Treatment of leprosy. Clin Dermatol. 2015;33(1):55-65. PMid:25432811
Alberto C, Michele B. Drug-induced liver injury: The role of drug metabolism and transport. J Clin Pharmacol. 2013;53(5):463-74. PMid:23436293
Dhavalshankh GP, Dhavalshankh AG, Gaurkar S. Assessment and comparison of liver functions in leprosy. Int J Cur Res Rev. 2017;9(5):26-32.
Bjornsson E, Olsson R. Outcome and prognostic markers in serve drug-induced liver disease. Hepatology. 2005;42(2):481- 9. https://doi.org/10.1002/hep.20800 PMid:16025496
Tsankov N, Kamarashev J. Rifampin in dermatology. Int J Dermatol. 1993;32(6):401-6. https://doi.org/10.1111/j.1365-4362.1993. tb02807.x PMid:8320018
Ferrari T, Araujo M, Ribeiro M. Hepatic involvement in lepromatous leprosy. Lepr Rev. 2002;73:72-5. PMid:11969129
Wakelin SH, Maibach H, Archer C. Handbook of Systematic Drug Treatment in Dermatology. 2nd ed., Vol. 118. New York: Free Press; 1998. p. 629-34.
Li HY, Yu XL, Zhang MS, Duan CX, Huang WB, Zhang SB, et al. Short-term multidrug therapy in multibacililary leprosy review of 80 case in two provinces of China (1983-1988). Int J Lepr.1988;57(3):622-7. PMid:2778368
Moet FJ, Meima A, Oskam L, dan Richardus JH. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr Rev. 2004;75:310-26. PMid:15682969
Baymakova M, Zaekov N, Andonova R, Pishmisheva M, Pekova L, Popov GT, et al. Infectious diseases in athletes. Gen Med. 2017;19(2):50-6. PMid:21623289
Venkatesan K, Neo D. Biochemical aspects of leprosy. In: Kumar B, Kar HK, editors. IAL Textbook of Leprosy. Vol. 2. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.; 2016. p. 125. https://doi.org/10.5005/jp/books/12958_9
Nigam PK, Gupta GB, Khare A. Hepatic involvement and hepatitis B surface antigen (Hbs Ag) in leprosy. Indian J Dermatol Venereol Leprol. 2003;69(1):32-4. PMid:17642821
Deps PD, Nasser S, Guerra P, Simon M, Birshner RD, Rodrigues KC. Adverse effect from multi-drug therapy in leprosy: A Brazilian study. Lepr Rev. 2007;78(3):216-22. PMid:18035772
Pollock NR, Rolland JP, Kumar S, Beattie PD, Jain S, Noubary F, et al. A paper based multiplexed transaminase test for low cost, point of care liver function testing. Sci Transl Med. 2012;4(152):1-11. https://doi.org/10.1126/scitranslmed.3003981
Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J. 2003;79(932):307-12. PMid:12840117
Wilcock A, Howard P. Rifampicin (INN Rifampicin). J Pain Symptom Manage. 2015;50(6):891-5. https://doi.org/10.1016/j.jpainsymman.2015.09.004 PMid:26432572
Gothwal S, Khosya S, Gharpure N. Dapsone hypersensitivity syndrome a fatal adverse drug reaction. Intern Med. 2013;3(1):1-5.
Copyright (c) 2020 Mila Darmi, Ramona Dumasari Lubis (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.